Wyke R J, Tsiquaye K N, Thornton A, White Y, Portmann B, Das P K, Zuckerman A J, Williams R
Lancet. 1979 Mar 10;1(8115):520-4. doi: 10.1016/s0140-6736(79)90945-0.
6 cases of non-A non-B hepatitis which followed administration of four different batches of concentrates of coagulation factor IX from commercial and non-commercial sources are described. Of 17 patients who received the concentrate on account of chronic liver disease, 4 developed hepatitis, and in 3 of these the illness proved fatal. The incubation periods ranged from 42 to 103 days (mean 65 days). 3 chimpanzees were inoculated with concentrate from the same batch used on the above patients, a further commercial batch upon which no adverse reactions had been reported, and plasma from a known non-A non-B carrier. All developed hepatitis after 10 weeks' incubation. Liver biopsy when serum-aminotransferase was at its highest level showed features consistent with acute hepatitis. As in the patients, viral markers for hepatitis A and B, cytomegalovirus, and Epstein-Barr virus were unchanged.
本文描述了6例非甲非乙型肝炎病例,这些病例是在使用了来自商业和非商业来源的4个不同批次的凝血因子IX浓缩物后出现的。在因慢性肝病而接受该浓缩物治疗的17名患者中,有4人患上了肝炎,其中3人病情 fatal。潜伏期为42至103天(平均65天)。3只黑猩猩分别接种了与上述患者使用的同一批次的浓缩物、另一批未报告有不良反应的商业浓缩物以及来自一名已知的非甲非乙型肝炎携带者的血浆。所有黑猩猩在10周的潜伏期后均患上了肝炎。当血清转氨酶处于最高水平时进行的肝活检显示出与急性肝炎相符的特征。与患者一样,甲型和乙型肝炎、巨细胞病毒和爱泼斯坦 - 巴尔病毒的病毒标志物均未改变。